Craft

Advanced
SomnoMed

SomnoMed

Stock Price

$0.4

2024-10-10

Market Capitalization

$80 M

2024-10-10

Revenue

$111.5 M

FY, 2025

SomnoMed Summary

Company Summary

Overview
SomnoMed is a company that provides treatment solutions for sleep-related breathing disorders. It deals with obstructive sleep apnea, snoring, and bruxism.
Type
Public
Status
Active
Founded
2004
HQ
Plano, TX, US | view all locations
Website
https://somnomed.com/au/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Matthew Conlon, Executive Vice President of Sales and Marketing

    • Lewis Meyers

      Lewis Meyers, Senior Director of Sales

      • Hamish Corlett, Non-Executive Director

        LocationsView all

        2 locations detected

        • Plano, TX HQ

          United States

          6513 Windcrest Dr #100

        • Crows Nest, NSW

          Australia

          20 Clarke St

        SomnoMed Financials

        Summary Financials

        Revenue (H1, 2026)
        $60.7M
        Gross profit (H1, 2026)
        $37.2M
        Net income (H1, 2026)
        $792.0K
        Cash (H1, 2026)
        $18.0M
        EBIT (H1, 2026)
        $2.8M
        Enterprise value
        $62.7M

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX